Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Eicosapentaenoic Acid and Indomethacin

Research Papers that Mention the Interaction

EPA supplementation for 8 weeks resulted in enhanced endogenous production of Δ12-PGJ3 that was blocked by indomethacin , a cyclooxygenase (COX) inhibitor.
Indomethacin blocked the EPA effect and increased the severity of BCR-ABL–induced CML and decreased apoptosis.
Cancer Prevention Research  •  2015  |  View Paper
Both inhibition of the COX pathway by indomethacin as well as inhibition of direct lipid peroxidation by antioxidants such as vitamin E and C diminished the anti-proliferative effects of AA as well as EPA.
Carcinogenesis  •  2003  |  View Paper
Moreover, incubation with indometacin (INDO) reduced the increased cortisol production induced by EPA and ARA, suggesting mediation by their cyclooxygenase-derived products.
The Journal of endocrinology  •  2006  |  View Paper
EPA also inhibited Na,K-ATPase: (-47% of basal activity, [EPA]=30 microg/ml, P <0.01), this effect was partially reversed by 100 microM indomethacin , a cyclo-oxygenase blocker.
Prostaglandins, leukotrienes, and essential fatty acids  •  2003  |  View Paper
Indomethacin (IND, micromol/l) attenuated relaxations in neonatal (approximately 25%), new-born and adult EPA (both approximately 45%).
Cardiovascular research  •  2001  |  View Paper
The relaxant effect of EPA (3–100 μM) was significantly inhibited by indomethacin (10 μM), the cyclo‐oxygenase inhibitor, but not by the nitric oxide (NO) synthesis inhibitor, Nω‐nitro‐L‐arginine methyl ester hydrochloride (L‐NAME, 100 μM).
British journal of pharmacology  •  2000  |  View Paper
Presence of indomethacin , an inhibitor of cyclo‐oxygenase reversed the effect of EPA on VLDL synthesis while diethyl carbamazine an inhibitor of lipoxygenase did not show any effect suggesting that the effect of EPA may be mediated through prostaglandins.
Biochemistry and molecular biology international  •  1997  |  View Paper
The arteriolar effect of EPA was reduced by indomethacin or superoxide dismutase plus catalase, indicating vasoactivity due to oxygen radicals formed by cyclooxygenase metabolism of EPA.
The American journal of physiology  •  1990  |  View Paper
Eicosapentaenoic acid stimulated water flow, and the stimulation was blocked with indomethacin.
Prostaglandins  •  1981  |  View Paper